Systematic Review and Network Meta-Analysis of Overall Survival Comparing 3 mg/kg Ipilimumab With Alternative Therapies in the Management of Pretreated Patients With Unresectable Stage III or IV Melanoma

OBJECTIVE. To compare the overall survival (OS) of patients treated with 3 mg/kg ipilimumab versus alternative systemic therapies in pretreated unresectable stage III or IV melanoma patients. METHODS. A systematic literature search was performed to identify relevant randomized clinical trials. From...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dequen, Pascale, Lorigan, Paul, Jansen, Jeroen P., van Baardewijk, Marc, Ouwens, Mario J.N.M., Kotapati, Srividya
Formato: Artigo
Lenguaje:Inglês
Publicado: AlphaMed Press 2012
Materias:
Academia-Pharma Intersect
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3500357/
https://ncbi.nlm.nih.gov/pubmed/23024154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0427
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares